Analysis of Adenoviral Attachment to Human Platelets

Overview

Journal Virol J

Publisher Biomed Central

Specialty Microbiology

Date 2009 Feb 19

PMID 19222836

Citations 10

Authors

Nilly Shimony

Gregory Elkin

Dror Kolodkin-Gal

Lina Krasny

Simcha Urieli-Shoval

Yosef S Haviv

Affiliations

Soon will be listed here.

Abstract

Background: Systemic adenoviral (Ad) vector administration is associated with thrombocytopenia. Recently, Ad interaction with mouse platelets emerged as a key player determining liver uptake and platelet clearance. However, whether Ad can activate platelets is controversial. Thus, in vitro analysis of Ad attachment to platelets is of interest.

Methods: We developed a direct flow cytometry assay to specifically detect Ad particles adherent to human platelets. The method was pre-validated in nucleated cells. Blocking assays were employed to specifically inhibit Ad attachment to platelets. Platelet activation was analyzed using annexin v flow cytometry.

Results: We found in vitro that Ad binding to human platelets is synergistically enhanced by the combination of platelet activation by thrombin and MnCl2 supplementation. Of note, Ad binding could activate human platelets. Platelets bound Ad displaying an RGD ligand in the fiber knob more efficiently than unmodified Ad. In contrast to a previous report, CAR expression was not detected on human platelets. Integrins appear to mediate Ad binding to platelets, at least partially. Finally, alphaIIbbeta3-deficient platelets from a patient with Glanzmann thrombasthenia could bind Ad 5-fold more efficiently than normal platelets.

Conclusion: The flow cytometry methodology developed herein allows the quantitative measurement of Ad attachment to platelets and may provide a useful in vitro approach to investigate Ad interaction with platelets.

Citing Articles

The role of platelets in central hubs of inflammation: A literature review.

Bo Y, Lu Q, Li B, Sha R, Yu H, Miao C Medicine (Baltimore). 2024; 103(19):e38115.

PMID: 38728509 PMC: 11081549. DOI: 10.1097/MD.0000000000038115.

Viruses and thrombocytopenia.

Rasizadeh R, Ebrahimi F, Kermanshahi A, Daei Sorkhabi A, Sarkesh A, Nahand J Heliyon. 2024; 10(6):e27844.

PMID: 38524607 PMC: 10957440. DOI: 10.1016/j.heliyon.2024.e27844.

Platelets in Viral Infections - Brave Soldiers or Trojan Horses.

Schrottmaier W, Schmuckenschlager A, Pirabe A, Assinger A Front Immunol. 2022; 13:856713.

PMID: 35419008 PMC: 9001014. DOI: 10.3389/fimmu.2022.856713.

Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspective.

Menter D, Afshar-Kharghan V, Shen J, Martch S, Maitra A, Kopetz S Cancer Metastasis Rev. 2022; 41(1):147-172.

PMID: 35022962 PMC: 8754476. DOI: 10.1007/s10555-022-10019-5.

Autoimmunity roots of the thrombotic events after COVID-19 vaccination.

Elrashdy F, Tambuwala M, Hassan S, Adadi P, Seyran M, Abd El-Aziz T Autoimmun Rev. 2021; 20(11):102941.

PMID: 34508917 PMC: 8426137. DOI: 10.1016/j.autrev.2021.102941.

References

Chen Y, OToole T, Leong L, Liu B, Diaz-Gonzalez F, Ginsberg M . Beta 3 integrin-mediated fibrin clot retraction by nucleated cells: differing behavior of alpha IIb beta 3 and alpha v beta 3. Blood. 1995; 86(7):2606-15. View

Eggerman T, Mondoro T, Lozier J, Vostal J . Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation. Hum Gene Ther. 2002; 13(1):125-8. DOI: 10.1089/10430340152712674. View

Othman M, Labelle A, Mazzetti I, Elbatarny H, Lillicrap D . Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood. 2006; 109(7):2832-9. DOI: 10.1182/blood-2006-06-032524. View

Relman D, Tuomanen E, Falkow S, Golenbock D, Saukkonen K, Wright S . Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell. 1990; 61(7):1375-82. DOI: 10.1016/0092-8674(90)90701-f. View

Bergelson J, Cunningham J, Droguett G, Krithivas A, Hong J, Horwitz M . Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997; 275(5304):1320-3. DOI: 10.1126/science.275.5304.1320. View

Urieli-Shoval S, Shubinsky G, Linke R, Fridkin M, Tabi I, Matzner Y . Adhesion of human platelets to serum amyloid A. Blood. 2002; 99(4):1224-9. DOI: 10.1182/blood.v99.4.1224. View

Wickham T, Filardo E, Cheresh D, Nemerow G . Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol. 1994; 127(1):257-64. PMC: 2120185. DOI: 10.1083/jcb.127.1.257. View

Lawler J, Hynes R . An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. Blood. 1989; 74(6):2022-7. View

Zhang Y, Bergelson J . Adenovirus receptors. J Virol. 2005; 79(19):12125-31. PMC: 1211528. DOI: 10.1128/JVI.79.19.12125-12131.2005. View

10.

Bergelson J, Shepley M, Chan B, Hemler M, Finberg R . Identification of the integrin VLA-2 as a receptor for echovirus 1. Science. 1992; 255(5052):1718-20. DOI: 10.1126/science.1553561. View

11.

Coller B, Cheresh D, Asch E, Seligsohn U . Platelet vitronectin receptor expression differentiates Iraqi-Jewish from Arab patients with Glanzmann thrombasthenia in Israel. Blood. 1991; 77(1):75-83. View

12.

Ruf A, Pick M, Deutsch V, Patscheke H, Goldfarb A, Rachmilewitz E . In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. Br J Haematol. 1997; 98(1):51-6. DOI: 10.1046/j.1365-2141.1997.1502965.x. View

13.

Stone D, Liu Y, Shayakhmetov D, Li Z, Ni S, Lieber A . Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J Virol. 2007; 81(9):4866-71. PMC: 1900148. DOI: 10.1128/JVI.02819-06. View

14.

Wolins N, Lozier J, Eggerman T, Jones E, Aguilar-Cordova E, Vostal J . Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance. Br J Haematol. 2003; 123(5):903-5. DOI: 10.1046/j.1365-2141.2003.04719.x. View

15.

Wickham T, Mathias P, Cheresh D, Nemerow G . Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993; 73(2):309-19. DOI: 10.1016/0092-8674(93)90231-e. View

16.

Scarborough R, Naughton M, Teng W, Rose J, Phillips D, Nannizzi L . Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem. 1993; 268(2):1066-73. View

17.

Coburn J, Leong J, Erban J . Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci U S A. 1993; 90(15):7059-63. PMC: 47075. DOI: 10.1073/pnas.90.15.7059. View

18.

Kiang A, Hartman Z, Everett R, Serra D, Jiang H, Frank M . Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. Mol Ther. 2006; 14(4):588-98. DOI: 10.1016/j.ymthe.2006.03.024. View

19.

Fox G, Parry N, Barnett P, McGinn B, Rowlands D, Brown F . The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J Gen Virol. 1989; 70 ( Pt 3):625-37. DOI: 10.1099/0022-1317-70-3-625. View

20.

Tallone T, Malin S, Samuelsson A, Wilbertz J, Miyahara M, Okamoto K . A mouse model for adenovirus gene delivery. Proc Natl Acad Sci U S A. 2001; 98(14):7910-5. PMC: 35442. DOI: 10.1073/pnas.141223398. View